Discovery of potent non-ATP competitive MK2 inhibitors

被引：0

作者：

Xiao, Dong ^{[1
]}

Palani, Anand ^{[1
]}

Aslanian, Robert ^{[1
]}

Huang, Xianhai ^{[1
]}

Degrado, Sylvia ^{[1
]}

Sofolarides, Michael ^{[1
]}

Chen, Xiao ^{[1
]}

Zhou, Wei ^{[1
]}

Rao, Ashwin ^{[1
]}

Guo, Zhuyan ^{[2
]}

Fossetta, James ^{[1
]}

Tian, Fang ^{[1
]}

Lundell, Daniel ^{[1
]}

Spacciapoli, Peter ^{[1
]}

Whitehurst, Charles ^{[1
]}

机构：

[1] Merck Res Labs, Rahway, NJ USA

[2] Merck Res Labs, CADD Grp, Rahway, NJ USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2012年 / 243卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

347-MEDI

引用

页数：1

共 50 条

[41] MEDI 70-Discovery and SAR studies of carboline- and pyrazinoindolone-based MK2 inhibitors
Gao, Donghong Amy
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
[42] Design, synthesis, and biological activity of hydroxyindoles as non-ATP competitive pp60c-src tyrosine kinase inhibitors.
Milkiewicz, KL
Marsilje, TH
Woodworth, RP
Bifulco, N
Hangauer, M
Hangauer, DG
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U545 - U545
[43] Theoretical Analysis of the Binding of Potential Inhibitors to Protein Kinases MK2 and MK3
Araujo, Pedro M. M.
da Silva, Luis Pinto
Esteves da Silva, Joaquim C. G.
MEDICINAL CHEMISTRY, 2015, 11 (06) : 573 - 579
[44] Synthesis and SAR studies of indole-based MK2 inhibitors
Xiong, Zhaoming
Gao, Donghong Amy
Cogan, Derek A.
Goldberg, Daniel R.
Hao, Ming-Hong
Moss, Neil
Pack, Edward
Pargellis, Chris
Skow, Donna
Trieselmann, Thomas
Werneburg, Brian
White, Andre
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (06) : 1994 - 1999
[45] Peptide Inhibitors of MK2 Show Promise for Inhibition of Abdominal Adhesions
Ward, Brian C.
Kavalukas, Sandra
Brugnano, Jamie
Barbul, Adrian
Panitch, Alyssa
JOURNAL OF SURGICAL RESEARCH, 2011, 169 (01) : E27 - E36
[46] Synthesis and in vivo activity of MK2 and MK2 substrate-selective p38αMAPK inhibitors in Werner syndrome cells
Davis, Terence
Bagley, Mark C.
Dix, Matthew C.
Murziani, Paola G. S.
Rokicki, Michal J.
Widdowson, Caroline S.
Zayed, Jameel M.
Bachler, Marcus A.
Kipling, David
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (24) : 6832 - 6835
[47] Discovery of Non-ATP-Competitive Inhibitors of Polo-like Kinase1
Yun, Taikangxiang
Qin, Tan
Liu, Ying
Lai, Luhua
CHEMMEDCHEM, 2016, 11 (07) : 713 - 717
[48] TAS-117, a highly potent and selective non-ATP competitive inhibitor of AKT, demonstrates a toxicity profile with manageable hyperglycemia in rats.
Moriyama, Kenji
Yamaguchi, Masahiro
Sugimoto, Shigeo
Matsumura, Hirofumi
Ninomiya, Fumiko
Besshi, Kazuhiko
Morita, Fumio
Hayashi, Taiji
Fujita, Ryouto
Fukushima, Hiroto
Shimomura, Toshiyasu
Yonekura, Kazuhiko
Utsugi, Teruhiro
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
[49] Dual inhibition of JAK2V617F and BCR-ABLT315I by a novel class of non-ATP competitive kinase inhibitors
Reddy, M. V. Ramana
Jatiani, Shashiclar S.
Cosenza, Stephen C.
Pallela, Venkat R.
Ha, A. Hee
Baker, Stacey
Samanta, Ajoy K.
Arlinghaus, Ralph B.
Maniar, Manoj
Reddy, E. Premkumar
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3413S - 3413S
[50] Targeting Subcellular Localization through the Polo-Box Domain: Non-ATP Competitive Inhibitors Recapitulate a PLK1 Phenotype
McInnes, Campbell
Estes, Kara
Baxter, Merissa
Yang, Zhengguan
Farag, Doaa Boshra
Johnston, Paul
Lazo, John S.
Wang, Jianjun
Wyatt, Michael D.
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (08) : 1683 - 1692

← 1 2 3 4 5 →